Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Phase Distribution

Ph not_applicable

57%

Ph phase_4

14%

Ph phase_2

14%

Ph early_phase_1

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Early Phase 1First-in-human

1(14.3%)

Phase 2Efficacy & side effects

1(14.3%)

Phase 4Post-market surveillance

1(14.3%)

N/ANon-phased studies

4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Other(2)

Detailed Status

Completed3

unknown2

Not yet recruiting1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (14.3%)

Phase 21 (14.3%)

Phase 41 (14.3%)

N/A4 (57.1%)

Trials by Status

not_yet_recruiting114%

unknown229%

completed343%

withdrawn114%

Recent Activity

0 active trials

Showing 5 of 7

not_yet_recruitingnot_applicable

AI-Enabled ECG Stratification and Timing of Potassium-Lowering Therapy in Patients With Hyperkalemia: A Target Trial Emulation Study

NCT07307729

completednot_applicable

Correction of Low Back Pain From Sacroiliac Malrotation With a Simple in Home Exercise

NCT03888235

completednot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT07307729Not Applicable

AI-Enabled ECG Stratification and Timing of Potassium-Lowering Therapy in Patients With Hyperkalemia: A Target Trial Emulation Study

Not Yet Recruiting

NCT03888235Not Applicable

Correction of Low Back Pain From Sacroiliac Malrotation With a Simple in Home Exercise

Completed

NCT02549599Not Applicable

Evaluating a Digital Health Information Tool

Completed

NCT03032042Phase 4

Intestinal Microbiome Post-Azythromycin/Albendazole Treatment

Withdrawn

NCT01201746Not Applicable

Influence of Periodontal Treatment on Systemic Inflammatory Mediators

Completed

NCT01633983Phase 2

Methotrexate for Central Serous Chorioretinopathy Treatment Trial

Unknown

NCT01150084Early Phase 1

"Step by Step": A Feasibility Study of the Promotion of Lunchtime Walking to Increase Physical Activity and Improve Mental Well-being in Sedentary Employees

Unknown

All 7 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 7